OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Rapidly-growing squamous cell carcinoma shortly after treatment with ingenol mebutate for actinic keratoses: report of two cases
Juan Antonio Moreno Romero, A. Campoy, Napoleón Paredes Pérez, et al.
British Journal of Dermatology (2015) Vol. 173, Iss. 6, pp. 1514-1517
Closed Access | Times Cited: 13
Juan Antonio Moreno Romero, A. Campoy, Napoleón Paredes Pérez, et al.
British Journal of Dermatology (2015) Vol. 173, Iss. 6, pp. 1514-1517
Closed Access | Times Cited: 13
Showing 13 citing articles:
Early and Late Onset Side Effects of Photodynamic Therapy
Francesco Borgia, Roberta Giuffrida, Emanuela Caradonna, et al.
Biomedicines (2018) Vol. 6, Iss. 1, pp. 12-12
Open Access | Times Cited: 137
Francesco Borgia, Roberta Giuffrida, Emanuela Caradonna, et al.
Biomedicines (2018) Vol. 6, Iss. 1, pp. 12-12
Open Access | Times Cited: 137
Pathogenesis of Keratinocyte Carcinomas and the Therapeutic Potential of Medicinal Plants and Phytochemicals
Andrea Jess Josiah, Danielle Twilley, Sreejarani Kesavan Pillai, et al.
Molecules (2021) Vol. 26, Iss. 7, pp. 1979-1979
Open Access | Times Cited: 17
Andrea Jess Josiah, Danielle Twilley, Sreejarani Kesavan Pillai, et al.
Molecules (2021) Vol. 26, Iss. 7, pp. 1979-1979
Open Access | Times Cited: 17
Safety of topical interventions for the treatment of actinic keratosis
Elias A. T. Koch, Anja Wessely, Theresa Steeb, et al.
Expert Opinion on Drug Safety (2021) Vol. 20, Iss. 7, pp. 801-814
Closed Access | Times Cited: 11
Elias A. T. Koch, Anja Wessely, Theresa Steeb, et al.
Expert Opinion on Drug Safety (2021) Vol. 20, Iss. 7, pp. 801-814
Closed Access | Times Cited: 11
Carcinome épidermoïde de croissance rapide après traitement par mébutate d’ingénol
M. Ehret, C. Velter, Martine Tebacher, et al.
Annales de Dermatologie et de Vénéréologie (2018) Vol. 145, Iss. 10, pp. 607-612
Closed Access | Times Cited: 9
M. Ehret, C. Velter, Martine Tebacher, et al.
Annales de Dermatologie et de Vénéréologie (2018) Vol. 145, Iss. 10, pp. 607-612
Closed Access | Times Cited: 9
The value of case reports in pharmacovigilance
I. García‐Doval, E. Segovia, H.J.A. Hunter, et al.
British Journal of Dermatology (2020) Vol. 183, Iss. 5, pp. 795-796
Open Access | Times Cited: 9
I. García‐Doval, E. Segovia, H.J.A. Hunter, et al.
British Journal of Dermatology (2020) Vol. 183, Iss. 5, pp. 795-796
Open Access | Times Cited: 9
Ingenol Mebutate Is Associated With Increased Reporting Odds for Squamous Cell Carcinoma in Actinic Keratosis Patients, a Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
Patrick Jedlowski
Journal of Cutaneous Medicine and Surgery (2022) Vol. 27, Iss. 1, pp. 39-43
Closed Access | Times Cited: 6
Patrick Jedlowski
Journal of Cutaneous Medicine and Surgery (2022) Vol. 27, Iss. 1, pp. 39-43
Closed Access | Times Cited: 6
Cytoplasmic Increase in Hsp70 Protein: A Potential New Biomarker of Early Infiltration of Cutaneous Squamous Cell Carcinoma Arising from Actinic Keratosis
M. Fernández‐Guarino, José J. Zamorano‐León, Antonio José López Farré, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1151-1151
Open Access | Times Cited: 8
M. Fernández‐Guarino, José J. Zamorano‐León, Antonio José López Farré, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1151-1151
Open Access | Times Cited: 8
Carcinomes épidermoïdes multiples après traitement par ingénol mébutate
C. Chabbert, M. Lévy, L. Legrand
Annales de Dermatologie et de Vénéréologie (2019) Vol. 146, Iss. 12, pp. 823-825
Closed Access | Times Cited: 5
C. Chabbert, M. Lévy, L. Legrand
Annales de Dermatologie et de Vénéréologie (2019) Vol. 146, Iss. 12, pp. 823-825
Closed Access | Times Cited: 5
Mesenchymal stem cell profile in actinic keratosis and its modification after topical application of ingenol mebutate
Anna Campanati, Ivan Bobyr, Giulia Sorgentoni, et al.
Journal of the European Academy of Dermatology and Venereology (2019) Vol. 34, Iss. 3
Closed Access | Times Cited: 1
Anna Campanati, Ivan Bobyr, Giulia Sorgentoni, et al.
Journal of the European Academy of Dermatology and Venereology (2019) Vol. 34, Iss. 3
Closed Access | Times Cited: 1
Ingenol Mebutate for the Treatment of Intraepidermal Squamous Cell Carcinoma.
Εfstathios Rallis, Angeliki Liakopoulou, Constantinos Christodoulopoulos
PubMed (2017) Vol. 10, Iss. 7, pp. 12-13
Closed Access
Εfstathios Rallis, Angeliki Liakopoulou, Constantinos Christodoulopoulos
PubMed (2017) Vol. 10, Iss. 7, pp. 12-13
Closed Access
Retrospective analysis of squamous cell carcinoma associated with ingenol mebutate reported to the US Food and Drug Administration
Yu Wang, Shari R. Lipner
Dermatologic Therapy (2020) Vol. 33, Iss. 6
Open Access
Yu Wang, Shari R. Lipner
Dermatologic Therapy (2020) Vol. 33, Iss. 6
Open Access
Influence of serum vitamin D level in the response of actinic keratosis to ingenol mebutate
Ricardo M. Alonso de Celada, Tamara Gracia‐Cazaña, Laura Nájera, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 12
Open Access
Ricardo M. Alonso de Celada, Tamara Gracia‐Cazaña, Laura Nájera, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 12
Open Access
